Antacid And Antigas Liquid
NDC Package 57896-655-12
Package Information
Antacid And Antigas (calcium carbonate, magnesium hydroxide, simethicone) liquids is shake well before useadults and children 12 years of age and older: take 10 mL to 20 mL (1 to 2 doses) between meals as needed, at bedtime,or as directed by a doctordo not take more than 60 mL (6 doses) in any 24-hour period or use the maximum dosage for more than 2 weekschildren under 12 years of age: ask a doctormL = milliliter. This formulation utilizes a liquid delivery system. Marketed by Geri-care Pharmaceuticals, Corp, this product is identified by NDC 57896-655 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1788932 - calcium carbonate 800 MG / magnesium hydroxide 270 MG / simethicone 80 MG in 10 mL Oral Suspension
- RxCUI: 1788932 - calcium carbonate 80 MG/ML / magnesium hydroxide 27 MG/ML / simethicone 8 MG/ML Oral Suspension
- RxCUI: 1788932 - calcium carbonate 800 MG / magnesium hydroxide 270 MG / simethicone 80 MG per 10 ML Oral Suspension
Clinical Specifications
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Skin Barrier Activity - [PE] (Physiologic Effect)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 57896 - Geri-care Pharmaceuticals, Corp
- 57896-655 - Antacid And Antigas
- 57896-655-12 - 355 mL in 1 BOTTLE
- 57896-655 - Antacid And Antigas
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57896-655-12 identifies a specific commercial package of 355 ml in 1 bottle of Antacid And Antigas, a human over the counter drug labeled by Geri-care Pharmaceuticals, Corp. This liquid is formulated for oral use and contains calcium carbonate; dimethicone; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-care Pharmaceuticals, Corp on December 01, 2025. The current certification is valid through December 31, 2026.
How is this Geri-care Pharmaceuticals, Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896065512. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.